These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Drug reduces incidence of sudden cardiac death. Am Fam Physician; 1980 Apr; 21(4):179, 182. PubMed ID: 7377063 [No Abstract] [Full Text] [Related]
23. [Effects of sulfinpyrazone on early ventricular fibrillation and 2d-phase arrhythmias in acute myocardial infarction (author's transl)]. Gülker H; Bender F; Thale J; Heuer H; Kristek J; Dorsel T; Pierchalla P Z Kardiol; 1980 Nov; 69(11):751-6. PubMed ID: 7467658 [TBL] [Abstract][Full Text] [Related]
24. [Sulfinpyrazone in the prevention of sudden cardiac death after myocardial infarct]. Foz M Med Clin (Barc); 1980 Jun; 75(1):32-4. PubMed ID: 7392709 [No Abstract] [Full Text] [Related]
25. Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. Cairns JA; Gent M; Singer J; Finnie KJ; Froggatt GM; Holder DA; Jablonsky G; Kostuk WJ; Melendez LJ; Myers MG N Engl J Med; 1985 Nov; 313(22):1369-75. PubMed ID: 3903504 [TBL] [Abstract][Full Text] [Related]
26. Cardiac death prevention in post-myocardial infarction patients: a review. Boissel JP; Leizorovicz A; Faucomprez C Acta Cardiol Suppl; 1980; (25):147-79. PubMed ID: 6103625 [No Abstract] [Full Text] [Related]
27. Sulphinpyrazone and warfarin after myocardial infarction. Domenet J Br Med J; 1979 Aug; 2(6188):497. PubMed ID: 487024 [No Abstract] [Full Text] [Related]
29. [Anticoagulants and thrombocyte aggregation inhibitors in or following myocardial infarct]. Rühle H Z Arztl Fortbild (Jena); 1985; 79(11):463-6. PubMed ID: 3901541 [No Abstract] [Full Text] [Related]
30. The Anturane reinfarction trial. Sherry S Thromb Haemost; 1979 Feb; 41(1):197-201. PubMed ID: 483231 [No Abstract] [Full Text] [Related]
31. Controlled ex-vivo effect of sulfinpyrazone on platelet function of myocardial infarction patients. Cortellaro M; Fassio G; Boschetti C; Basagni M; Polli EE Haematologica; 1979 Apr; 64(2):173-89. PubMed ID: 112008 [No Abstract] [Full Text] [Related]
35. Sulphinpyrazone, cardiac infarction, and the prevention of death: a successful trial or another tribulation? Br Med J; 1978 Apr; 1(6118):941-2. PubMed ID: 638542 [No Abstract] [Full Text] [Related]
36. Reduction of mortality by sulphinpyrazone after experimental myocardial infarction in the rat. Brunner L; Stepanek J; Brunner H J Pharm Pharmacol; 1980 Oct; 32(10):714-5. PubMed ID: 6107349 [No Abstract] [Full Text] [Related]
37. The anturane reinfarction trial. Rothlin M N Engl J Med; 1980 Jul; 303(1):48. PubMed ID: 6103510 [No Abstract] [Full Text] [Related]
38. Sulphinpyrazone and prevention of death after myocardial infarction. Green KG Br Med J; 1978 Aug; 2(6134):435-6. PubMed ID: 687968 [No Abstract] [Full Text] [Related]
39. Sulphinpyrazone and the platelet serotoninergic mechanism in ischaemic heart disease. Puri VK; Rawat A; Sharma A; Mehrotra A; Hasan M; Shanker K; Verma M; Sinha JN; Bhargava KP Br Med J (Clin Res Ed); 1986 Sep; 293(6547):591-3. PubMed ID: 3092937 [TBL] [Abstract][Full Text] [Related]
40. Anturan: new use for an old drug. Can Med Assoc J; 1980 Mar; 122(6):714-6. PubMed ID: 6988068 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]